San Antonio-A small Texas biotech that develops women’s health products, including a generic birth control ring, has received a $960,000 grant from the Department of Defense to continue early stage work on experimental treatments for triple-negative breast cancer.
Evestra, which is located just outside of San Antonio, in Schertz, TX, plans to use the three-year grant to study the toxicology and pharmacology of its potential candidates of antiprogestins, according to CEO Ze’ev Shaked. Antiprogestins play a role regulating hormones, and may stop cancer cell growth, according to the National Cancer Institute. The company will also work with Ratna Vadlamudi, a… Read more »
UNDERWRITERS AND PARTNERS